Cite
, Daniel D, Kalali A, et al. Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders. Innov Clin Neurosci. 2016;13(1):27-33
, Daniel, D., Kalali, A., West, M., Walling, D., Hilt, D., Engelhardt, N., Alphs, L., Loebel, A., Vanover, K., Atkinson, S., Opler, M., Sachs, G., Nations, K., & Brady, C. (2016). Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders. Innovations in clinical neuroscience, 13(1), 27-33.
, et al. "Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders." Innovations in clinical neuroscience vol. 13,1 (2016): 27-33.
, Daniel D, Kalali A, West M, Walling D, Hilt D, Engelhardt N, Alphs L, Loebel A, Vanover K, Atkinson S, Opler M, Sachs G, Nations K, Brady C. Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders. Innov Clin Neurosci. 2016 Feb 01;13(1):27-33. eCollection 2016. PMID: 27413584; PMCID: PMC4896826.
Copy
Download .nbib